3+ min ago   (53+ words) Triple-negative breast cancer is the form of the disease that clinicians fear most. Lacking the three molecular targets — the estrogen receptor, the progesterone receptor and the HER2 protein — that anchor modern targeted therapies, it leaves patients with fewer options and a…...

3+ min ago   (603+ words) When a dog develops mammary tumors, veterinarians almost never find just one. Roughly half to sixty percent of dogs diagnosed with canine mammary tumors carry multiple, physically distinct growths at the same time, a phenomenon known as synchronous tumor development....

19+ min ago   (571+ words) For patients diagnosed with small kidney cancers tucked dangerously close to the organ’s blood vessels, urine-collecting system, or neighboring bowel, treatment options have long been fraught with compromise. Surgery risks sacrificing precious kidney function, while conventional heat-based ablation risks burning…...

19+ min ago   (55+ words) Immune checkpoint inhibitors have rewritten the outlook for some patients with gastrointestinal cancers, turning once uniformly fatal diagnoses into manageable chronic conditions for a fortunate minority. Yet for every dramatic response there are many more patients whose tumours barely flinch,…...

19+ min ago   (758+ words) Scientists in Japan have taken one of the most detailed looks yet at how large-scale genome disruption inside tumor cells may quietly rewire the immune landscape around them, and their findings could help explain why some cancers mount virtually no…...

28+ min ago   (75+ words) Gastric cancer continues to rank among the most lethal malignancies worldwide, and a new study published in Medical Oncology has identified a molecular culprit that may explain how tumors in the stomach not only grow aggressively but also dismantle the…...

28+ min ago   (651+ words) Patients with extensive-stage small cell lung cancer, one of the most difficult malignancies to treat once first-line therapy fails, may soon have a more convenient way to receive an immunotherapy that has already changed the treatment landscape....

28+ min ago   (476+ words) A synthetic molecule from a family of compounds long prized by medicinal chemists may offer a new line of attack against one of the most stubborn pathogens in modern hospitals....

28+ min ago   (539+ words) A mitochondrial enzyme long known simply as a workhorse of cellular energy production has been revealed as a powerful suppressor of colorectal cancer, one of the most common and deadly malignancies worldwide....

28+ min ago   (721+ words) A new qualitative study from China offers one of the most detailed maps to date of what patients with cardiovascular-kidney-metabolic syndrome actually value about their health, and the picture that emerges is strikingly broader than the clinical targets that dominate…...